ProMIS Neurosciences, Inc.

NasdaqCM:PMN Stock Report

Market Cap: US$29.1m

ProMIS Neurosciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:PMN Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
24 Sep 24BuyUS$255,750Madge ShafmasterIndividual200,000US$1.30
17 Sep 24BuyUS$116,880Michael GordonIndividual93,223US$1.40
14 Aug 24BuyUS$12,492Patrick KirwinIndividual10,000US$1.25

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of PMN?
Owner TypeNumber of SharesOwnership Percentage
VC/PE Firms2,790,6988.54%
Institutions2,925,4798.95%
Hedge Funds4,599,29714.1%
Individual Insiders8,127,81324.9%
General Public14,245,90343.6%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 73.1%.

Top Shareholders

Top 25 shareholders own 56.33% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
8.68%
Jeremy Sclar
2,838,163US$2.5m-13.5%no data
8.54%
Great Point Partners, LLC
2,790,698US$2.5m0%1.1%
8.17%
Armistice Capital LLC
2,670,000US$2.4m0%0.06%
7.32%
Jonathan Shafmaster
2,394,063US$2.1m0%no data
6.35%
Michael Gordon
2,075,629US$1.8m79.1%no data
5.9%
Sphera Funds Management Ltd
1,929,297US$1.7m6.34%0.3%
4.87%
Ally Bridge Group
1,592,605US$1.4m50.3%0.64%
1.78%
Altium Capital Management LP
581,395US$517.5k0%0.17%
1.18%
Heights Capital Management, Inc.
386,894US$344.4k0%0.06%
0.64%
Madge Shafmaster
208,333US$185.4k0%no data
0.58%
Cheyne Capital Management (UK) LLP
189,767US$168.9k0%5.0%
0.49%
Eugene Williams
159,930US$142.4k0%no data
0.35%
Neil Cashman
114,921US$102.3k0%no data
0.3%
Patrick Kirwin
99,096US$88.2k11.2%no data
0.29%
Michael Gordon
93,223US$83.0k0%no data
0.19%
William Wyman
62,937US$56.0k0%no data
0.16%
Gail Farfel
53,192US$47.3k0%no data
0.094%
Affinity Asset Advisors, LLC
30,643US$27.3k-88.5%0.01%
0.093%
BMO Asset Management Corp.
30,366US$27.0k0%no data
0.09%
Hara Capital LLC
29,416US$26.2k0%0.02%
0.08%
IEQ Capital, LLC
26,042US$23.2k0%no data
0.061%
Fiduciary Trust Company
20,008US$17.8k0%no data
0.046%
Max Milbury
14,997US$13.3k0%no data
0.037%
Scotiabank Global Banking and Markets, Asset Management Division
12,122US$10.8k0%no data
0.035%
Claret Asset Management Corp
11,330US$10.1k4.62%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/20 14:33
End of Day Share Price 2025/01/17 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

ProMIS Neurosciences, Inc. is covered by 3 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Thomas ShraderBTIG
Eddie HickmanGuggenheim Securities, LLC
Douglas LoeLeede Jones Gable Inc